Clinical characteristics and outcomes of cardiomyopathies related to immune-mediated diseases.
Saved in:
| Title: | Clinical characteristics and outcomes of cardiomyopathies related to immune-mediated diseases. |
|---|---|
| Authors: | Rossi VA; Department of Cardiology, Maastricht University, CARIM School for Cardiovascular Diseases, The Netherlands.; Department of Cardiology, University Heart Center, University Hospital and University of Zurich, Zurich, Switzerland., Sikking MA; Department of Cardiology, Maastricht University, CARIM School for Cardiovascular Diseases, The Netherlands., Folgheraiter A; Cardiovascular Department, Centre for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart, Amsterdam, The Netherlands., Loco CP; Cardiovascular Department, Centre for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart, Amsterdam, The Netherlands., Dominguez F; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart, Amsterdam, The Netherlands.; Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda and Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain., Nihant BSC; Department of Cardiology, Maastricht University, CARIM School for Cardiovascular Diseases, The Netherlands., Stroeks SLVM; Department of Cardiology, Maastricht University, CARIM School for Cardiovascular Diseases, The Netherlands., Henkens MTHM; Department of Cardiology, Maastricht University, CARIM School for Cardiovascular Diseases, The Netherlands.; Netherlands Heart Institute (NLHI), Utrecht, The Netherlands.; Department of Pathology, Maastricht University Medical Centre, Maastricht, The Netherlands., Mora-Ayestarán N; Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda and Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain., Ramos-López N; Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda and Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain., Sinagra G; Cardiovascular Department, Centre for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart, Amsterdam, The Netherlands., Garcia-Pavia P; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart, Amsterdam, The Netherlands.; Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda and Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; Universidad Francisco de Vitoria, Pozuelo de Alarcón, Spain., Ruschitzka F; Department of Cardiology, University Heart Center, University Hospital and University of Zurich, Zurich, Switzerland., Merlo M; Cardiovascular Department, Centre for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart, Amsterdam, The Netherlands., Verdonschot JAJ; Department of Cardiology, Maastricht University, CARIM School for Cardiovascular Diseases, The Netherlands., Heymans SRB; Department of Cardiology, Maastricht University, CARIM School for Cardiovascular Diseases, The Netherlands.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart, Amsterdam, The Netherlands.; Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium. |
| Source: | European journal of heart failure [Eur J Heart Fail] 2026 May 11; Vol. 28 (2), pp. 278-287. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
